cytokine
PreclinicalBiologic
cytokine is one of 31 biologic programs targeting Pleural effusion. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
30
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
54 competitors in Pleural Effusion
#DrugCompanyPhaseTrials
1Avastin
BBio-Thera Solutions
Phase 3
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3
Opdivo
Bristol-Myers SquibbPhase 2
Sclerosol
SSciarra
Approved
Aleve
Alnylam PharmaceuticalsPhase 2
MS Contin
Merck & Co.Phase 2
Gemzar
Johnson & JohnsonPhase 2
Platinol
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 2
Decadron
AAspen Global Incorporated
Phase 2
Advil
KKenvue Brands
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for cytokine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details